Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma

The current standard of care for anal squamous cell carcinoma (ASCC) is definitive concurrent chemoradiotherapy (CRT). However, about a third of patients may experience treatment failure. Recently, immunotherapy has emerged as a novel strategy for metastatic ASCC patients. We evaluated the efficacy...

Descripción completa

Detalles Bibliográficos

Autores principales:	Fang He, Mo Chen, Qi-jun Yao, Zhi-min Liu, Yandong Zhao, Fengyun Pei, Jian Zheng, Yuan-hong Gao, Jun Huang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2024-12-01
Colección:	Translational Oncology
Materias:	Surgery Chemoradiotherapy Immunotherapy Squamous cell carcinoma Anal canal
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S1936523324002602
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!